Search Within

Sujata Patil

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (278)
  2. Journal Article (230)
  3. Correspondence (1)
  4. Research Letter (1)
  5. Review (1)
Groups
  1. Biostatistics Service (511)
  2. Epidemiology and Biostatistics (511)
  3. Department of Medicine (363)
  4. Solid Tumor Oncology Division (358)
  5. Survivorship Research (323)
  6. Surgery (247)

More Groups

People
  1. Clifford Hudis (141)
  2. Larry Norton (97)
  3. Robert Motzer (93)
  4. Monica Morrow (83)
  5. Darren Feldman (81)
  6. Edi Brogi (65)

More People

Years
  1. 2024 (3)
  2. 2023 (3)
  3. 2022 (10)
  4. 2021 (24)
  5. 2020 (29)
  6. 2019 (31)

More Years

Publications
  1. Journal of Clinical Oncology (170)
  2. Annals of Surgical Oncology (67)
  3. Cancer Research (55)
  4. Cancer (23)
  5. Breast Cancer Research and Treatment (18)
  6. Clinical Cancer Research (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (172)
  2. Springer (92)
  3. American Association for Cancer Research (71)
  4. Elsevier Inc. (34)
  5. Wiley Blackwell (33)
  6. Oxford University Press (19)

More Publishers

Results (511)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Breast-conserving surgery in bilateral breast cancer
    Journal Article

    O'brien, J. A.; Ho, A.; Wright, G. P.; Stempel, M.; Patil, S.; Krause, K.; Morrow, M.; Gemignani, M. L.
    Annals of Surgical Oncology (2015)

    Fulltext@MSK | Save
  • Decreasing recurrence rates for ductal carcinoma in situ: Analysis of 2996 women treated with breast-conserving surgery over 30 years
    Journal Article

    Subhedar, P.; Olcese, C.; Patil, S.; Morrow, M.; Van Zee, K. J.
    Annals of Surgical Oncology (2015)

    Fulltext@MSK | Save
  • Relationship between margin width and recurrence of ductal carcinoma in situ: Analysis of 2996 women treated with breast-conserving surgery for 30 years
    Journal Article

    Van Zee, K. J.; Subhedar, P.; Olcese, C.; Patil, S.; Morrow, M.
    Annals of Surgery (2015)

    Fulltext@MSK | Save
  • A phase II trial of everolimus (E) and bevacizumab (B) in advanced non-clear cell renal cell cancer (ncRCC) to show efficacy in patients (pts) with papillary features
    Meeting Abstract

    Voss, M. H.; Chen, Y. B.; Chaim, J.; Coskey, D. T.; Woo, K.; Redzematovic, A.; Wang, P.; Lee, W.; Patil, S.; Molina, A. M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II study of weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer (MBC): Updated progression-free survival with overall survival result
    Meeting Abstract

    Smyth, L. M.; Iyengar, N. M.; Chandarlapaty, S.; Sugarman, S.; Comen, E. A.; Drullinsky, P.; Sklarin, N. T.; Traina, T. A.; Troso-Sandoval, T. A.; Patil, S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Oncotype DX in BRCA-associated vs. sporadic breast cancers: Differences based on germline mutation status and potential implications for adjuvant systemic therapy (AST)
    Meeting Abstract

    Shah, P. D.; Patil, S.; Dickler, M. N.; Offit, K.; Hudis, C. A.; Robson, M. E.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Prevalence of hypomagnesemia in patients with HER2-positive breast cancer receiving pertuzumab treatment
    Meeting Abstract

    Proverbs-Singh, T. A.; Cadoo, K. A.; Torre, G.; Patil, S.; Gucalp, A.; Dang, C. T.; Hudis, C. A.; Glezerman, I. G.; Traina, T. A.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Long-term rates of ipsilateral breast tumor recurrence (IBTR) for women with ductal carcinoma in situ (DCIS) meeting LORIS trial eligibility criteria undergoing standard therapy
    Meeting Abstract

    Pilewskie, M. L.; Olcese, C.; Patil, S.; Van Zee, K. J.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Characterization of dominant T-cell clones by T-cell receptor (TCR) deep sequencing as a potential predictive biomarker to neoadjuvant trastuzumab (tras) in HER2-positive (HER2+) breast cancer
    Meeting Abstract

    Page, D. B.; Wen, Y. H.; Brogi, E.; Yuan, J. D.; Emerson, R. O.; Patil, S.; Dang, C. T.; Norton, L.; Hudis, C. A.; Mcarthur, H. L.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A combined screening approach of Fracture (Fx) Risk Algorithm (FRAX) and Trabecular Bone Score (TBS) to identify osteoporotic-range fracture risk (ORFR) in breast cancer (BC) patients treated with adjuvant aromatase inhibitor (AI)
    Meeting Abstract

    Page, D. B.; Mariotti, V.; Davydov, O.; Patil, S.; Hans, D.; Hudis, C. A.; Farooki, A.; Fornier, M. N.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save